An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AMLDyantha I. van der Lee, Marieke Griffioen, Kees L. M. C. Franken et al.|Cancers|2021Cited by 14
Hotspot DNA Methyltransferase 3A (DNMT3A) and Isocitrate Dehydrogenase 1 and 2 (IDH1/2) Mutations in Acute Myeloid Leukemia and Their Relevance as Targets for ImmunotherapyNadine E. Struckman, Marieke Griffioen, Rob C. M. de Jong et al.|Biomedicines|2024Cited by 6
A T-cell receptor targeting RUNX1 frameshift mutations in acute myeloid leukemiaNadine E. Struckman, Marieke Griffioen, Georgia Koutsoumpli et al.|Leukemia|2025Cited by 3
Immunotherapy Targeting Mutant Nucleophosmin-1 on Acute Myeloid LeukemiaGeorgia Koutsoumpli, Marieke Griffioen, Dyantha I. van der Lee et al.|Blood|2022Cited by 0